Suspected contamination leads to recall of meningitis C vaccineBMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b896 (Published 03 March 2009) Cite this as: BMJ 2009;338:b896
- Caroline White
Two batches of meningitis C vaccine distributed to general practices across England have been recalled by the medicines watchdog amid fears that they may have been contaminated.
The manufacturer, Novartis Vaccines, raised the alarm last week after routine sampling of a shipment of doses from the same two batches air freighted to the United States showed contamination with Staphylococcus aureus.
The sterility of the solvent, aluminium hydroxide, which is used to mix the vaccine, had been compromised.
In all 61 117 doses of meningitis C vaccine (Menjugate Kit) were sent to the UK, of which 17 000 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial